Genetic amniocentesis complications: Is the incidence overrated?

Gynecologic and Obstetric Investigation

Volumn 58, Issue 2, 2004, Pages 100-104

  Nassar, Anwar H ^a,d   Martin, Dibe ^a   González Quintero, Victor Hugo ^a   Gómez Marín, Orlando ^b   Salman, Fawwaz ^a   Gutierrez, Alfredo ^c   O'Sullivan, Mary J ^a  

^a Division of Perinatology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JACKSON MEMORIAL HOSPITAL   (United States)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Complications; Fetal loss; Genetic amniocentesis

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; AMNION FLUID; COLOR; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENETIC ANALYSIS; GESTATIONAL AGE; HUMAN; IATROGENIC DISEASE; INCIDENCE; INJECTION SITE; KARYOTYPE; LOGISTIC REGRESSION ANALYSIS; MATERNAL AGE; MEMBRANE RUPTURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; ULTRASOUND; VAGINA BLEEDING;

EID: 4344610162     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078793     Document Type: Review

References (11)

1. Elias S, Simpson JL, Bombard AT: Amniocentesis and fetal blood sampling; in Milunsky A (ed): Genetic Disorders and the Fetus, ed 4. Baltimore, Johns Hopkins University Press, 1998, pp 53-82.
2. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B: Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986;1:1287-1293.
3. NICHD Amniocentesis Registry: The Safety and Accuracy of Mid-Trimester Amniocentesis. Washington, Department of Health, Education, and Welfare, 1976, pp 78-190.
4. Crandall BF, Howard J, Lebherz TB, Rubinstein L, Sample WF, Sarti D: Follow-up of 2000 second-trimester amniocenteses. Obstet Gynecol 1980;56:625-628.
5. Blessed WB, Lacoste H, Welch RA: Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J Obstet Gynecol 2001;184: 1340-1344.
6. Papantoniou NE, Daskalakis GJ, Tziotis JG, Kitmirides SJ, Mesogitis SA, Antsaklis AJ: Risk factors predisposing to fetal loss following a second trimester amniocentesis. BJOG 2001; 108:1053-1056.
7. Simpson NE, Dallaire L, Miller JR, Siminovich L, Hamerton JL, Miller J, McKeen C: Prenatal diagnosis of genetic disease in Canada: Report of a collaborative study. Can Med Assoc J 1976;115:739-748.
8. No authors cited: Report to the Medical Research Council by their Working Party on Amniocentesis: An assessment of the hazards of amniocentesis. Br J Obstet Gynaecol 1987; 85(suppl 2):1.
9. The Canadian Early and Midtrimester Amniocentesis Trial (CEMAT) Group: Randomized trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998; 351:242-247.
10. Saltvedt S, Almström H: Fetal loss rate after second trimester amniocentesis at different gestational age. Acta Obstet Gynecol Scand 1999;78:10-14.
11. Giorlandino C, Mobili L, Bilancioni E, D'Alessio P, Carcioppolo O, Gentili P, Vizzone A: Transplacental amniocentesis: Is it really a higher-risk procedure? Prenat Diagn 1994;14: 803-806.